Skip to main content

CNO Summit Diary: Entergy Nuclear CNO Calls Visiting Fukushima Daiichi 'Life-Altering'

The past two days in Japan, U.S. chief nuclear officers have toured Fukushima Daini and Daiichi, and with respect to the latter, left the experience appreciably changed. We've made a point each day of inviting the CNOs to the very back of our tour bus and asking them to share their experiences on camera with us.

It's true that every CNO we spoke with identified the Daiichi visit as life-altering, but no reaction seemed better representative of the CNOs than that of Jeff Forbes, Executive Vice President and Chief Nuclear Officer for Entergy Nuclear. Just watch.

Please remember to follow our updates on Twitter using the #CNOSummit hash tag.

Comments

Bill Rodgers said…
Mr. Forbes mentioned that the radiation levels were increasing as they were about 5 miles out.

It would be helpful to put some context to that comment.

What were the rad levels? What was the dose rate?

Letting that comment hang there without some context just leaves the door open for anti-nuclear types to make a big deal of the comment.

Good to see US based nuclear professionals having an opportunity to tour Fukushima and provide commentary outside the normal media channels.
jimwg said…
@Bill Rodgers said...

Super Ditto to that! That simply can't be underscored and overemphasized enough! When dealing with the public the nuclear community MUST breakdown their native technical terms and concepts to grass-roots layman comprehensive levels as everyday life comparative ideas and measurements.

James Greenidge
Queens NY

Popular posts from this blog

Fluor Invests in NuScale

You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...

Wednesday Update

From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...